Skip to main content

Market Overview

Citi Maintains Buy Rating On MDRX

Share:

Citi is maintaining its Buy rating on shares of Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX).

“Allscripts filed an 8-K after market close in which it made three announcements: 1) A new credit arrangement reduces interest margin for borrowings under the senior credit facilities by 75 bps,” Citi writes.

“2) MDRX entered into an agreement with Affiliated Computer Services (ACS) where ACS will provide remote hosting services for the company's Sunrise acute care clients; and 3) MDRX' Chief Technology Officer, John Gomez, is resigning to pursue other interests.

“Despite the savings from the credit agreement and outsourcing, we are disappointed to see Gomez go and have some concerns with hosting strategy. The change to the interest rates could be worth $0.01- $0.02 in 2011. We see the news as a modest incremental negative for the company.”

Allscripts Healthcare closed Wednesday at $22.49.

 

Related Articles (MDRX + ACS)

View Comments and Join the Discussion!

Posted-In: Allscripts Healthcare Citi John GomezAnalyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com